These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25856090)

  • 1. Could inducible protein-10 and heparin-binding hemagglutinin improve the detection of Mycobacterium tuberculosis-infected subjects in a country with low incidence of tuberculosis?
    Molicotti P; Bua A; Cubeddu M; Ruggeri M; Mura MS; Pirina P; Zanetti S
    Infect Dis (Lond); 2015 Aug; 47(8):563-7. PubMed ID: 25856090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
    Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.
    Sali M; Buonsenso D; D'Alfonso P; De Maio F; Ceccarelli M; Battah B; Palucci I; Chiacchio T; Goletti D; Sanguinetti M; Valentini P; Delogu G
    J Infect; 2018 Dec; 77(6):526-533. PubMed ID: 30267797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response.
    Butera O; Chiacchio T; Carrara S; Casetti R; Vanini V; Meraviglia S; Guggino G; Dieli F; Vecchi M; Lauria FN; Marruchella A; Laurenti P; Singh M; Caccamo N; Girardi E; Goletti D
    BMC Infect Dis; 2009 Nov; 9():182. PubMed ID: 19930588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy.
    Kabeer BS; Raja A; Raman B; Thangaraj S; Leportier M; Ippolito G; Girardi E; Lagrange PH; Goletti D
    BMC Infect Dis; 2011 May; 11():135. PubMed ID: 21595874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative biomarkers for classification of latent tuberculosis infection status in pregnant women with borderline Quantiferon plus results.
    Tesfaye F; Sturegård E; Walles J; Winqvist N; Balcha TT; Karlson S; Mulleta D; Isberg PE; Jansson M; Björkman P
    Tuberculosis (Edinb); 2020 Sep; 124():101984. PubMed ID: 32829076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis.
    Hougardy JM; Schepers K; Place S; Drowart A; Lechevin V; Verscheure V; Debrie AS; Doherty TM; Van Vooren JP; Locht C; Mascart F
    PLoS One; 2007 Oct; 2(10):e926. PubMed ID: 17912342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders.
    Delogu G; Chiacchio T; Vanini V; Butera O; Cuzzi G; Bua A; Molicotti P; Zanetti S; Lauria FN; Grisetti S; Magnavita N; Fadda G; Girardi E; Goletti D
    PLoS One; 2011 Mar; 6(3):e18315. PubMed ID: 21479248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
    Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis.
    Goletti D; Raja A; Ahamed Kabeer BS; Rodrigues C; Sodha A; Butera O; Carrara S; Vernet G; Longuet C; Ippolito G; Thangaraj S; Leportier M; Girardi E; Lagrange PH
    J Infect; 2010 Jul; 61(2):133-43. PubMed ID: 20470822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of interferon-gamma whole blood assay with tuberculin skin test for the diagnosis of tuberculosis infection in tuberculosis contacts].
    Oztürk N; Sürücüoğlu S; Ozkütük N; Gazi H; Akçali S; Köroğlu G; Ciçek C
    Mikrobiyol Bul; 2007 Apr; 41(2):193-202. PubMed ID: 17682705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of interferon gamma-inducible protein-10 and interferon gamma-based QuantiFERON TB Gold assays with tuberculin skin test in HIV-infected subjects.
    Kabeer BS; Sikhamani R; Raja A
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):236-43. PubMed ID: 21996360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper.
    Aabye MG; Latorre I; Diaz J; Maldonado J; Mialdea I; Eugen-Olsen J; Ravn P; Dominguez J; Ruhwald M
    Eur Respir J; 2013 Aug; 42(2):495-503. PubMed ID: 23349445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IP-10 is an accurate biomarker for the diagnosis of tuberculosis in children.
    Latorre I; Díaz J; Mialdea I; Serra-Vidal M; Altet N; Prat C; Díez N; Escribano A; Casas I; Rodrigo C; Ausina V; Ruhwald M; Domínguez J
    J Infect; 2014 Dec; 69(6):590-9. PubMed ID: 24975172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
    Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
    J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.